Inhibitors of histamine methylation in brain promote formation of imidazoleacetic acid, which interacts with GABA receptors.
Inhibitors of histamine methylation in brain promote formation of imidazoleacetic acid, which interacts with GABA receptors.
复制标题
大脑中组胺甲基化的抑制剂促进咪唑乙酸的形成,咪唑乙酸与 GABA 受体相互作用。
DOI:
10.1046/j.1471-4159.1997.68010142.x
复制
发表时间:
1997
影响因子:
4.7
通讯作者:
Lee,WS
中科院分区:
文献类型:
--
作者:
Prell,GD;Morrishow,AM;Duoyon,E;Lee,WS
In brain, the precursor of imidazoleacetic acid (IAA), a GABAAagonist but a GABACantagonist, is not known. In the periphery, IAA derives from oxidation of histamine. But in brain, histamine is thought to be metabolized solely by histamine methyltransferase (HMT), formingtele‐methylhistamine (t‐MH) andtele‐methylimidazoleacetic acid (t‐MIAA). We showed that [3H]histamine (intracerebroventricularly) could be converted to IAA in brains of rats, a process increased by inhibition of HMT. This demonstrated that brain can oxidize histamine and suggested that endogenous histamine might also be oxidized if HMT activity were reduced. We examined, in rat cerebral cortex, effects of the following HMT inhibitors (mg/kg i.p.): metoprine (10), tacrine (10), velnacrine (10, 30), and physostigmine (1, 2). Tacrine was a potent inhibitor (Ki∼ 22 nM). To measure histamine in tissue that contained HMT inhibitors, we developed a gas chromatography‐mass spectrometry method. After 2 h, all drugs reduced endogenous levels of t‐MH and t‐MIAA and increased levels of histamine and IAA. Our results show that inhibition of HMT promotes oxidation of histamine in brain, probably by shunting histamine to an alternative metabolic pathway. Formation of IAA provides a novel interaction between histaminergic and GABAergic systems in brain. Accumulation of IAA should be considered when inhibitors of HMT are used to probe brain histamine function.